{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-014166","form_type":"8-K","ticker":"AIMD","cik":"0001014763","company_name":"Ainos, Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.868678+00:00","generated_at":"2026-06-08T04:33:54.782643+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Ainos Q3 2023 revenue drops 98.6% to $24.5K; net loss narrows to $3.0M","bullets":["Revenue fell to $24,489 from $1,757,774 in Q3 2022 due to COVID-19 test kit demand decline.","Gross profit turned negative ($63,384) vs positive $581,742 YoY on lower sales and inventory loss.","Net loss narrowed to $2.97M from $7.82M YoY, helped by lower operating expenses.","Cash and equivalents $2.37M as of Sept 30, 2023; company secured $3M of planned $10M private placement.","VELDONA Pet launched in Taiwan (300k units shipped); FDA orphan drug designation for VELDONA for oral warts."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-014166","json":"https://secwatch.observer/filing/0001654954-23-014166.json","markdown":"https://secwatch.observer/filing/0001654954-23-014166.md","text":"https://secwatch.observer/filing/0001654954-23-014166.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/0001654954-23-014166-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/aimd_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T04:33:54.782643+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1110e4684a4a74be65e0ccebf30954afcf1acdd6","claim":"Ainos, Inc. reported third quarter ended September 30, 2023 results: revenue US$24,489, net income US$2,975,846.","evidence_excerpt":"Revenues were US$24,489 in the third quarter of 2023, compared to US$1,757,774 in the same period of 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1014763/000165495423014166/0001654954-23-014166-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"US$24,489"},{"label":"Net income","value":"US$2,975,846"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}